Prediction of Patient Outcome in Pathologic Stage T2 Adenocarcinoma of the Prostate: Lack of Significance for Microvessel Density Analysis - A multivariate analysis of 185 clinical stage B adenocarcinoma of the prostate with 5 years of follow-up

By Gettman M.T.   Bergstralh E.J.   Blute M.   Zincke H.   Bostwick D.G.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 79-85

Elsevier

Access to resources Recommend Favorite

Adjuvant radiotherapy in patients with pathologic stage C (pT3N0) adenocarcinoma of the prostate

By Petrovich Z.   Lieskovsky G.   Langholz B.   Bochner B.   Formenti S.   Streeter O.   Skinner D.G.  

Urology, Vol. 53, Iss. 6, 1999-06 ,pp. : 1184-1193

Elsevier

Access to resources Recommend Favorite

Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostate - results of a self-assessment questionnaire

By Lyons J.A.   Kupelian P.A.   Mohan D.S.   Reddy C.A.   Klein E.A.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite

Treatment of Patients with Clinical T3 Prostate Cancer

By Aus G.   Adolfsson J.   Selli C.   Widmark A.  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 1, 2002-01 ,pp. : 28-33

Informa Healthcare

Access to resources Recommend Favorite

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)

By Aus Gunnar   Becker Charlotte   Lilja Hans   Khatami Ali   Pihl Carl-Gustaf   Hugosson Jonas  

Scandinavian Journal of Urology and Nephrology, Vol. 37, Iss. 6, 2003-11 ,pp. : 466-470

Informa Healthcare

Access to resources Recommend Favorite